“To the best of our team's knowledge, this project represents the first time an Alabama medical center has examined deep brain stimulation for depression,” said Matthew Macaluso, D.O., director of the ...

Johnson & Johnson’s Spravato nasal spray has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral antidepressants, the FDA announced ...

What Is TMS (Transcranial Magnetic Stimulation)? Transcranial magnetic stimulation (TMS) is a noninvasive procedure that uses magnetic pulses to treat and prevent the symptoms of depression and other ...

Flow’s headset is the first tDCS device approved by the FDA ...

Zuranolone is a novel, rapidly acting, oral medication for the treatment of postpartum depression. Zuranolone is generally ...

Until recently, clinical depression treatments have fallen into just two categories: psychotherapy and antidepressant medications. But this year, the U.S. Food and Drug Administration cleared the ...

A new study led by the University of Miami Miller School of Medicine's Kirill Martemyanov, Ph.D., and international ...

DENVER, COLORADO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines to treat ...

For years, clinicians have noticed that people living with major depression often show unexpectedly fragile bones. What sounded like a coincidence is now being reframed as a tightly wired “brain–bone ...

Although many therapies and medications now exist for major depression, roughly one in three diagnosed patients still suffer from treatment-resistant depression—a form of the disorder that does not ...

Major depressive disorder (MDD) not only takes a toll on your mental health, but can also put a strain on your finances. The cost of treating depression in the United States topped $320 billion in ...